A. Miyamae, S. Koda, S. Kitamura, Y. Okamoto, and Y. Morimoto. X-ray crystallographic characterization of two polymorphs of 8-(2-methoxycarbonylamino-6-methylbenzyloxy)-2-methyl-3-(2-propynyl)imidazo[1,2-a]pyridine, J. Pharm. Sci.
79: 189–195 (1990).
Google Scholar
P. A. Saindon, N. S. Cauchon, P. A. Sutton, C. J. Chang, G. Peck, and S. R. Byrn. Solid-state nuclear magnetic resonsance (NMR) spectra of pharmaceutical dosage forms, Pharm. Res.
10: 197–203 (1993).
Google Scholar
D. E. Bugay. Solid-state nuclear magnetic resonance spectroscopy: Theory and pharmaceutical applications, Pharm. Res.
10: 317–327.
J. K. Haleblian and W. C. McCrone. Pharmaceutical Applications of Polymorphism, J. Pharm. Sci.
58: 911 (1969).
Google Scholar
W. I. Higuchi, P. K. Lau, T. Higuchi, and J. W. Shell. Polymorphism and Drug Availability, J. Pharm. Sci.
52: 150–153 (1963).
Google Scholar
D. P. Ip, G. S. Brenner, J. M. Stevenson, S. Lindenbaum, A. W. Douglas, S. D. Klein, and J. A. McCauley. High resolution spectroscopic evidence and solution calorimetry studies on the polymorphs of enalapril maleate, Int. J. Pharm.
28: 183–191 (1986).
Google Scholar
Y. Matsuda, E. Tatsumi, E. Chiba, and Y. Miwa. Kinetic study of the polymorphic transformations of phenylbutazone, J. Pharm. Sci.
73: 1453–1460 (1984).
Google Scholar
V. P. Tanninen and J. Yliruusi. X-ray powder diffraction profile fitting in quantitative determination of two polymorphs from their powder mixture, Int. J. Pharm.
81: 169–177 (1992).
Google Scholar
G. A. Stephenson, J. G. Stowell, P. H. Toma, D. E. Dorman, J. R. Greene, and S. R. Byrn. Solid-State Analysis of Polymorphic, Isomorphic, and Solvated Forms of Dirithromycin, J. Am. Chem. Soc.
116: 5766–5773 (1994).
Google Scholar
C. A. Hirsch, R. J. Messenger, and J. L. Brannon. Fenoprofen: drug form selection and preformulation stability studies, J. Pharm. Sci.
67: 231–236 (1978).
Google Scholar
S. Niazi. Thermodynamics of mercaptopurine dehydration, J. Pharm. Sci.
67: 488–491 (1978).
Google Scholar
T. Ishida, M. Doi, M. Shimamoto, N. Minamino, K. Nonaka, and M. Inoue. Physicochemical properties of crystalline forms of ethynylestradiol solvates: comparison of thermal behavior with x-ray crystal structure, J. Pharm. Sci.
78: 274 (1989).
Google Scholar
G. Zografi, D. Hollenbeck, S. Laughlin, M. Pikal, J. Schwartz, and L. VanCampen. Report of the advisory panel on moisture specifications, Pharmacopeial Forum: 1459–1474 (1991).
C. T. Lin, P. Perrier, G. G. Clay, P. A. Sutton, and S. R. Byrn. Solid-State Photooxidation of Cortisol-21-tert-butylacetate to Cortisone-21-tert-butylacetate, J. Org. Chem.
47: 2978–82 (1982).
Google Scholar
S. R. Byrn, P. A. Sutton, B. Tobias, J. Frye, and P. Main. Crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of prednisolone tert-butylacetate, J. Am. Chem. Soc.
110: 1609–1614 (1988).
Google Scholar
Y. Matsuda and E. Tatsumi. Physicochemical characterization of furosemide modifications, Intl. J. Pharm.
60: 11–26 (1990).
Google Scholar
C. Doherty and P. York. Furosemide crystal forms; solid state and physicochemical analyses, Int. J. Pharm.
47: 141–155 (1988).
Google Scholar
E. Shefter and T. Higuchi. Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals, J. Pharm. Sci.
52: 781–791 (1963).
Google Scholar
I. Himuro, Y. Tsuda, K. Sekiguchi, I. Horikoshi, and M. Kanke. Studies on the method of size reduction of medicinal compounds. IV. Solvate formation of chloramphenicol and its application to size reduction, Chem. Pharm. Bull.
19: 1034–1040 (1971).
Google Scholar
M. J. Pikal, A. L. Lukes, J. E. Lang, and K. Gaines. Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability, J. Pharm. Sci.
67: 767–769 (1978).
Google Scholar
E. Fukuoka, M. Makita, and S. Yamamura. Some physicochemical properties of glassy indomethacin, Chem. Pharm. Bull.
34: 4314–4321 (1986).
Google Scholar
E. Fukuoka, M. Makita, and S. Yamamura. Glassy state of pharmaceuticals III. Thermal properties and stability of glassy pharmaceuticals and their binary glass systems, Chem. Pharm. Bull.
37: 1047–1050 (1989).
Google Scholar